Literature DB >> 11848331

Plasmapheresis: an adjunct therapy in severe progressive neuropsychiatric lupus.

Y A Gokhale1, S Bhide, S Rajadhyaksha, L S Bichile, N K Hase.   

Abstract

OBJECTIVE: We report our experience with use of plasmapheresis (PP) as an adjunct therapy in severe progressive neuropsychiatric systemic lupus erythematosus (NPSLE).
METHOD: Three patients of NPSLE (including 2 with status epilepticus) who were progressively worsening on steroids or combination of pulse cyclophosphamide (CPM) and steroids were treated with PP followed by synchronized CPM. Pre and post treatment SLE Disease Activity Index (SLEDAI) and laboratory tests were carried out.
RESULTS: Significant clinical improvement with decrease in SLEDAI occurred immediately following PP. Mean SLEDAI before and after PP were 33 and 11. Mean erythrocyte sedimentation rate decreased from 121 to 31. Rebound flare of disease activity noted in two patients between 7th-10th day requiring additional immunosuppressants or steroids.
CONCLUSIONS: PP used as an adjunct therapy in severe, progressive NPSLE is well tolerated and can turn the patient around. PP should be followed by synchronized pulse CPM to prevent disease flare.

Entities:  

Mesh:

Year:  2001        PMID: 11848331

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  2 in total

1.  Retrospective study of plasma exchange in children with systemic lupus erythematosus.

Authors:  Elizabeth C Wright; Kjell Tullus; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2004-08-05       Impact factor: 3.714

Review 2.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.